Viewing Study NCT06413433

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-03-08 @ 1:51 AM
Study NCT ID: NCT06413433
Status: RECRUITING
Last Update Posted: 2025-11-21
First Post: 2024-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Sponsor: Axsome Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Binge-Eating Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Binge eating disorder View
None BED View
None Solriamfetol View
None Sunosi View
None Axsome View
None Non-stimulant therapy View
None Dopamine norepinephrine reuptake inhibitor View
None Trace amine-associated receptor 1 (TAAR1) agonist View